Yunrong Lu

Dr. Yunrong Lu

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2017 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Open access
PDF file
YLYunrong Lu
Yunrong Lu
YZYan Zhang
Yan Zhang
YRYing‐Bo Rao
Ying‐Bo Rao
Xi ChenXi Chen
Xi Chen
HLHan‐Fen Lou
Han‐Fen Lou
LHLi‐Wei Hu
Li‐Wei Hu
Summary: There is strong evidence of roles of the hypothalamus‐pituitary‐adrenal axis and nitric oxide (NO) synthase‐NO system in depression, but the relationship between them is unknown. The aim of this study, therefore, was to elucidate whether there is any correlation between NO and corticotropin‐releasing hormone (CRH) in major depressive disorder (MDD) patients. In 16 outpatients with MDD and 18 healthy controls, the plasma amino acids citrulline (Cit) and arginine (Arg) were determined by high‐performance liquid chromatography, and CRH levels was measured by radioimmunoassay. The Cit/Arg ratio was calculated as an index of NO synthesis. Correlations between NO and CRH were examined with the Spearman test. Before treatment, no significant correlation was observed between the plasma NO level and CRH levels in MDD patients. The plasma NO levels were significantly higher in MDD patients. A significant correlation was found between NO levels and Hamilton Depression Rating Scale (HAMD) scores in MDD patients. The plasma CRH levels were significantly higher in MDD patients than in controls. After monotherapy for 2 months, the NO levels had dramatically declined but were also higher than those in the controls. This study is the first report of the absence of a significant correlation between plasma NO and CRH levels, although both levels are elevated in MDD patients. Furthermore, the strong links between the plasma NO levels and the HAMD scores, as well as the increased NO reduction after remission, suggest that NO plays a key role in depression and may be an indicator of therapeutic success.

3 March 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
XLXiang-Yao Li
Xiang-Yao Li
YRYingbo Rao
Yingbo Rao
GLGuo-Hao Li
Guo-Hao Li
LHLuxi He
Luxi He
YWYaohan Wang
Yaohan Wang
YLYunrong Lu
Yunrong Lu
Major depressive disorder (MDD) is a widespread psychiatric condition, recognized as the third leading cause of global disease burden in 2008. In the context of MDD, alterations in synaptic transmission within the prefrontal cortex (PFC) are associated with PFC hypoactivation, a key factor in cognitive function and mood regulation. Given the high energy demands of the central nervous system, these synaptic changes suggest a metabolic imbalance within the PFC of MDD patients. However, the cellular mechanisms underlying this metabolic dysregulation remain not fully elucidated. This study employs single-nucleus RNA sequencing (snRNA-seq) data to predict metabolic alterations in the dorsolateral PFC (DLPFC) of MDD patients. Our analysis revealed cell type-specific metabolic patterns, notably the disruption of oxidative phosphorylation and carbohydrate metabolism in the DLPFC of MDD patients. Gene set enrichment analysis based on human phenotype ontology predicted alterations in serum lactate levels in MDD patients, corroborated by the observed decrease in lactate levels in MDD patients compared to 47 age-matched healthy controls (HCs). This transcriptional analysis offers novel insights into the metabolic disturbances associated with MDD and the energy dynamics underlying DLPFC hypoactivation. These findings are instrumental for comprehending the pathophysiology of MDD and may guide the development of innovative therapeutic strategies.

29 January 2025 in Behavioral Sciences
Verified
Journal Article
Open access
PDF file
WHWenli He
Wenli He
QHQiong Hu
Qiong Hu
WJWang Jiejie
Wang Jiejie
YRYingbo Rao
Yingbo Rao
CCChen Cheng
Chen Cheng
YLYunrong Lu
Yunrong Lu
Stressful life events are important risk factors in the development of adolescent depression. Executive function is significant in the stress–depression link. However, it is not clear whether there is a specific effect for subcomponents of executive function (working memory, inhibition, and shifting). Therefore, the present study recruited 213 adolescents (mean age (Mage) = 15.19 years, SD = 1.27, range = 12.00–18.00 years, and 53.00% girls) and measured their perceived stress using the questionnaire of the Adolescent Self-Rating Life Events Checklist, working memory ability by two-back tasks, inhibition ability by Stroop tasks, and shifting ability by Wisconsin Card-Sorting tasks. Results showed that stressful life events positively correlated with adolescents’ depression, while stressful life events negatively linked with working memory and inhibition. Depression was negatively associated with working memory and inhibition. No significant correlation was found between shifting and either stressful life events or depression. Mediation analyses revealed that working memory and inhibition mediated the link between stressful life events and adolescent depression, while shifting did not show a mediating effect. Our findings provide further evidence for the precise effect of executive function in the stress–depression link, implicating that different subcomponents should be considered to provide targeted intervention to alleviate adolescents’ depressive symptoms.

29 July 2025 in Psychiatry and Clinical Psychopharmacology
Verified
Journal Article
Open access
PFPing Fang
Ping Fang
GLGuo-Hao Li
Guo-Hao Li
YRYing-Bo Rao
Ying-Bo Rao
CCChen Cheng
Chen Cheng
WHWen-Li He
Wen-Li He
YLYunrong Lu
Yunrong Lu
Background: This study aimed to investigate the serum levels of interleukin 2, interleukin 6 (IL-6), interleukin 10, and tumor necrosis factor-alpha in patients with postpartum depression (PPD) and to explore their potential as biomarkers for PPD and comorbid anxiety using machine learning techniques. Methods: Serum samples were collected from 53 patients diagnosed with PPD and 35 healthy controls. Cytokine levels were measured using a flow cytometer analyzer. Machine learning models, including Multinomial Logistic Regression, Decision Trees, Random Forest, and Support Vector Machines (SVMs), were developed to predict PPD and comorbid anxiety based on cytokine levels. Results: Patients with PPD exhibited significantly elevated serum levels of IL-6 compared to the control group. A positive correlation was found between psychological anxiety scores and IL-6 levels (r = 0.483, P < .001). Machine learning models, particularly the Random Forest and SVMs, demonstrated high accuracy in predicting PPD and comorbid anxiety, with IL-6 being identified as a key predictor. Conclusion: The activation of serum cytokines is evident in PPD patients, with IL-6 potentially serving as an auxiliary biomarker for the diagnosis of PPD and comorbid anxiety. The incorporation of machine learning techniques has enhanced the understanding of the complex relationships between cytokines and PPD, with IL-6 levels showing a correlation to the severity of clinical symptoms.

29 June 2021 in Psychiatry and Clinical Psychopharmacology
Verified
Journal Article
Open access
CCChen Cheng
Chen Cheng
YRYing-Bo Rao
Ying-Bo Rao
YLYunrong Lu
Yunrong Lu
Mental health,COVID-2019 epidemic,clinical laboratory staff

21 September 2022 in Psychiatry and Clinical Psychopharmacology
Verified
Journal Article
Open access
YRYing-Bo Rao
Ying-Bo Rao
CCChen Cheng
Chen Cheng
YLYunrong Lu
Yunrong Lu
WWWei-Gen Wu
Wei-Gen Wu
XXxiaoping xia
xiaoping xia
Autoantibody,antinuclear antibodies,thyroid autoantibody,acute psychiatric disorders,retrospective study